Skip to main content

Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Privacy Incident Alert

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 16, 2016

Drug Name	Review Type	Class	Manufacturer
Prezcobix	New Drug Initial Review	HIV	Johnson & Johnson
Envarsus XR	New Drug Initial Review	Immunosupressant	Veloxis Pharmaceuticals
Nucala	New Drug Initial Review	Severe Asthma	Glaxo Smith Kline
Zomacton	New Drug Initial Review	Growth Hormone	Ferring Pharmaceuticals
Veltassa	New Drug Initial Review	Potassium Binder	Relypsa, Inc.
Zepatier	New Drug initial Review	Hepatitis C	Merck
Jadenu	New Drug Appeal	Iron Chelator	Novartis
Triumeq	New Drug Appeal	HIV	ViiV Healthcare
Kitabis	New Drug Appeal	Cystic Fibrosis	Pari Respiratory, Inc.
Invega Trinza	New Drug Appeal	Long Acting Antipsychotic	Johnson & Johnson